For: | Liao YP, Jiang JL, Zou WY, Xu DR, Li J. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients. World J Gastroenterol 2015; 21(14): 4284-4292 [PMID: 25892880 DOI: 10.3748/wjg.v21.i14.4284] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4284.htm |
Number | Citing Articles |
1 |
Soheil Tavakolpour, Seyed Moayed Alavian, Shahnaz Sali. Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review. Hepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.35810
|
2 |
Danping Xiong, Wen Cai, Weifeng Zhao. Risk factors of HBV reactivation in leukemia patients with resolved HBV infection after allogeneic hematopoietic stem cell transplantation. Clinics and Research in Hepatology and Gastroenterology 2024; 48(8): 102447 doi: 10.1016/j.clinre.2024.102447
|
3 |
Yibo Wu, He Huang, Yi Luo. Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.610500
|
4 |
Aida Siyahian, Saad Ullah Malik, Adeela Mushtaq, Carol L. Howe, Aneela Majeed, Tirdad Zangeneh, Samar Iftikhar, Shahid Habib, Umar Zahid, Irbaz Bin Riaz, Zabih Warraich, Warda Faridi, Faiz Anwer. Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis. Biology of Blood and Marrow Transplantation 2018; 24(7): 1483 doi: 10.1016/j.bbmt.2018.02.027
|
5 |
Hildegard T. Greinix. Establishing a Hematopoietic Stem Cell Transplantation Unit. 2018; : 197 doi: 10.1007/978-3-319-59358-6_14
|
6 |
Anaïs Jaillais, Anne Herber-Mayne, Louis D’Alteroche, Alain Landau, Yacine Merrouche, Stéphane Vignot. Hépatite B : dépistage et traitement en oncologie. Bulletin du Cancer 2018; 105(2): 162 doi: 10.1016/j.bulcan.2017.09.003
|
7 |
Yu Akahoshi, Hideki Nakasone, Koji Kawamura, Machiko Kusuda, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Aki Tanihara, Masaharu Tamaki, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda. Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT. Blood Advances 2019; 3(21): 3287 doi: 10.1182/bloodadvances.2019000629
|
8 |
Yi-Chang Liu, Chi-Mu Hsu, Samuel Yien Hsiao, Hui-Hua Hsiao. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Personalized Medicine 2021; 11(11): 1108 doi: 10.3390/jpm11111108
|
9 |
Yibo Wu, Yi Chen, Panpan Zhu, Baodong Ye, Ying Lu, Jimin Shi, Yamin Tan, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Jianping Lan, Ting Si, Lihong Ni, He Huang, Yi Luo. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area. Annals of Hematology 2022; 101(3): 631 doi: 10.1007/s00277-021-04730-6
|